GlycoMimetics Newsroom

Analysts Have Conflicting Sentiments on These Healthcare Companies: Doximity (DOCS), Avinger (AVGR) and GlycoMimetics (GLYC)

TipRanksAug 9 19:13

GlycoMimetics Analyst Ratings

BenzingaJul 27 02:45

TD Cowen Downgrades GlycoMimetics(GLYC.US) to Hold Rating

Futu NewsJul 26 18:33

GlycoMimetics (GLYC) Was Downgraded to a Hold Rating at TD Cowen

TipRanksJul 26 17:47

Capital One Financial Maintains GlycoMimetics(GLYC.US) With Hold Rating, Maintains Target Price $0.5

Futu NewsJul 26 03:32

GlycoMimetics: Strategic Overhaul and FDA Setback Justify Hold Rating

TipRanksJul 26 03:17

H.C. Wainwright Maintains GlycoMimetics(GLYC.US) With Hold Rating

Futu NewsJul 25 23:32

H.C. Wainwright Remains a Hold on GlycoMimetics (GLYC)

TipRanksJul 25 23:03

GlycoMimetics Analyst Ratings

BenzingaJun 5 04:15

Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50

MT NewswiresMay 7 19:16

GlycoMimetics' Uproleselan: Hold Rating Amidst Strategic Reevaluation and Uncertain Future

TipRanksMay 7 03:10

GlycoMimetics Analyst Ratings

BenzingaMay 7 02:05

HC Wainwright & Co. : Decrease GlycoMimetics (GLYC.US) rating from buy to neutral.

Zhitong FinanceMay 7 02:01

Analysts Have Conflicting Sentiments on These Healthcare Companies: GlycoMimetics (GLYC) and Gossamer Bio (GOSS)

TipRanksMay 7 00:15

Analysts' Top Healthcare Picks: Praxis Precision Medicines (PRAX), GlycoMimetics (GLYC)

TipRanksMar 28 20:25

Positive Outlook for GlycoMimetics: Buy Rating Affirmed Amid Anticipated Pivotal Trial Results and Strategic Growth Initiatives

TipRanksMar 28 09:30

GlycoMimetics Analyst Ratings

BenzingaMar 28 01:45

Buy Rating on GlycoMimetics Backed by Strong Financials and Promising Phase 3 Trial of Uproleselan

TipRanksMar 27 23:40

Promising Outlook for GlycoMimetics' Uproleselan in AML Treatment: A Buy Rating With Adjusted Price Target

TipRanksFeb 22 20:46

Buy Rating Affirmed for GlycoMimetics Amidst Phase 3 Progress and Breakthrough Therapy Designation for Uproleselan

TipRanksJan 3 22:26